Raffi Bekeredjian
Latest contributions
M-TEER with Mitraclip Gen5
19 Dec 2025
An 83-year-old female patient with HFrEF due to NICM and a history of arterial hypertension and persistent atrial fibrillation was referred with worsening exertional dyspnea, severe functional mitral regurgitation and moderate tricuspid regurgitation.
How would you treat this patient?
Author
Mitral and tricuspid hotline: long-term outcomes
20 May 2025 – From EuroPCR 2025
Review long-term outcomes of transcatheter edge-to-edge repair (TEER) for mitral and tricuspid valve disease in this session. Highlights include pivotal trial results, mortality risk prediction tools, management of procedural failures, and real-world data, providing comprehensive insights into patient prognosis and therapeutic impact.
Transcatheter Mitral Valve therapy : repair or replace?
13 Dec 2021
Watch the replay of this PCR Webinar on mitral valve with R. Bekeredjian, F. Maisano, F. Praz and P. Sorajja.
TriClip therapy: here now, here to stay
19 May 2022 – From EuroPCR 2022
Discover how tricuspid clip dedicated therapy allows treating a broad range of anatomies through real-life cases. Also, learn about its real-world outcomes and the performance in different tricuspid regurgitation patient profiles.
Tailoring mitral and tricuspid dedicated clip therapies by unlocking their full potential
22 Nov 2021 – From PCR London Valves 2021
Plunge into the universe of mitral and tricuspid in this PCR London Valves 2021 session, and learn how to optimize patient selection and tailor our procedural strategy, understand how to optimize patient outcomes with dedicated devices, and experience how to maximize the use of the G4...
#2 - Transcatheter Mitral Valve therapy : repair or replace?
19 Oct 2021
Watch the replay of this PCR Webinar on mitral valve with R. Bekeredjian, F. Maisano, F. Praz and P. Sorajja.
